Tag: Clinical Trials

10 years after Vioxx scandal, pharmaceutical companies caught again misleading patients using false claims

March 2, 2016

Screenshot 2016-03-02 11.06.12

Pharmaceutical companies have once again used industry influence to conceal data and make false claims about a high-profile medication.

Today The New York Times reported that Johnson & Johnson and Bayer – the companies behind the anti-clotting drug Xarelto – are responsible for critical laboratory data being left out of a letter published in The New England Journal of Medicine discussing the safety of the medication. Lawyers representing patients suing the two major pharmaceutical companies claim that both corporations were complicit by remaining silent about the data concealed from the publication.

Continue reading “10 years after Vioxx scandal, pharmaceutical companies caught again misleading patients using false claims”

The FDA, Finances, & Feminism: Why the third time was the charm for so-called “female Viagra”

August 21, 2015
Via http://www.europeanpharmaceuticalreview.com/34157/news/industry-news/fda-approves-female-libido-drug-addyi/
Via European Pharmaceutical Review

By: Elizabeth Yuko, Ph.D.

Money can’t buy happiness, but evidently is instrumental in gaining FDA approval for controversial drugs with low efficacy and significant side effects.

On Tuesday, the U.S. Food and Drug Administration (FDA) approved Addyi (Flibanserin) to treat acquired, generalized hypoactive sexual desire disorder (HSDD) in premenopausal women, after denying approval in 2010 and 2013 because the risks of the medication did not outweigh the benefits.

Continue reading “The FDA, Finances, & Feminism: Why the third time was the charm for so-called “female Viagra””

Fordham RETI Santander Universities Fellow Tackles HIV Prevention in India through Research & Clinical Practice

April 8, 2015
Arun_Photo1
Dr. Arunansu Talukdar

Fordham University HIV and Drug Abuse Prevention Research Ethics Training Institute (RETI) Fellow Dr. Arunansu Talukdar is not just conducting research on HIV prevention – as a physician, he is practicing it as well.

Talukdar is a member of the fourth cohort of RETI fellows, and was the 2014 recipient of the Fordham University Center for Ethics Education / Santander Universities International Scholarship, which covers the cost of his travel to Fordham for two consecutive summer training institutes, as well as the cost of his mentored research project (MRP). His MRP examines voluntariness of consent to research involving women participating at a clinic-based HIV intervention trial in Kolkata, India.

Continue reading “Fordham RETI Santander Universities Fellow Tackles HIV Prevention in India through Research & Clinical Practice”

Dr. Celia B. Fisher Contributes to National Discussion on Ethical Review & Oversight Issues in Standard of Care Research

January 9, 2015

Common clinical practices might lack a robust evidence base if there have not been empirical interventional research studies to compare an array of available routine or standard treatment options. Fordham University Center for Ethics Education Director Dr. Celia B. Fisher, an internationally renowned expert on empirical research on research ethics, recently traveled to Washington, D.C. to participate in an Institute of Medicine (IOM) workshop aimed to inform practice and policy of regulated research studies involving standard of care interventions.

Continue reading “Dr. Celia B. Fisher Contributes to National Discussion on Ethical Review & Oversight Issues in Standard of Care Research”

Clinical trials can & should be designed to include people with disabilities

February 18, 2014

Clinical trials tend to exclude vulnerable populations, such as people with disabilities. Speaking to Joshua Howgego of SciDev.net, Dr. Celia B. Fisher, Director of the Center for Ethics Education, explained that clinical trials can — and should — be designed to include people with disabilities.

Continue reading “Clinical trials can & should be designed to include people with disabilities”

Fighting Stigma with Knowledge: RETI Fellow Brandon Brown Focuses on Peru

October 31, 2013
Dr. Brandon Brown
Dr. Brandon Brown

By: Elizabeth Yuko, Ph.D.

A new video from the University of California Irvine attempts to decrease the stigma attached to HIV through the personal stories of those affected by HIV/AIDS in Peru. Focusing on the only gay men’s health community center in Peru (Epicentro), the video features the work of Dr. Brandon Brown, the director of the Global Health Research Education and Translation (GHREAT) Initiative in the Program in Public Health at UC Irvine and a Fordham University HIV Prevention Research Ethics Training Institute (RETI) fellow.

Continue reading “Fighting Stigma with Knowledge: RETI Fellow Brandon Brown Focuses on Peru”

Ethics & Society Newsfeed: June 12th 2013

June 12, 2013

Is everyone out to steal my umbrella?
Is it ethical to take someone’s umbrella from the umbrella basket at the front of a restaurant if your similar-looking umbrella was taken by someone else? Also, is it ethical to wear non-prescription eyeglasses to appear more intelligent?

Behind Cry for Help from China Labor Camp
An Oregon woman buys Halloween decorations, and finds a letter from a Chinese labor camp prisoner inside. Who actually wrote the letter and what could and should be done?

Continue reading “Ethics & Society Newsfeed: June 12th 2013”